As your go-to resource for cardiometabolic risk reduction, follow CMHC for the latest news, research, and innovations to advance your career and practice!
Visitors should treat PeptideStack as a research and comparison starting point
In contrast to other proteins that do not engage FcRn, the two ligands are prevented from progressing to the lysosomes for degradation by binding to the receptor in early sorting endosomes 41,43,47,49,50
Jamy Ard, Co-Director, Weight Management Center at Wake Forest Baptist Health This article dives into how brands can use science-backed ingredient solutions to create high-protein, high-fiber, nutrient-dense products that resonate with GLP-1-era consumers